Effect of modulating voltage-dependent calcium channels on cholecystokinin and acetylcholine-induced contractions of the guinea pig gallbladder

Regul Pept. 1996 May 7;63(1):31-7. doi: 10.1016/0167-0115(96)00023-7.

Abstract

The aim of this study was to investigate the role of extracellular Ca2+ utilization in cholecystokinin (CCK) and acetylcholine-induced guinea pig gallbladder contractions by using agents that modulate influx of extracellular Ca2+ through voltage-dependent calcium channels.

Methods: Guinea pig gallbladder muscle strips were studied isometrically at Lmax in vitro.

Results: (1) Acetylcholine and CCK caused dose-dependent contractions, with EDmax of 10(-4) and 10(-6) M, respectively. (2) Preventing influx of extracellular Ca2+ by incubation in Ca(2+)-free/0.1 mM EGTA solution inhibited the acetylcholine (10(-4) M)-induced contraction by 60 +/- 3% compared to only 46 +/- 5% (P < 0.05) for CCK (10(-6) M)-induced contraction. (3) Nifedipine (3 microM) inhibited the response to acetylcholine (10(-4) M) by 54 +/- 3%, compared to only 34 +/- 3% (P < 0.01) for CCK (10(-6) M). (4) Bay K 8644 (10(-7) M) significantly increased (P < 0.05) the contractile responses to low doses of each agonist: acetylcholine (10(-6) M) by 121 +/- 44% and CCK (10(-9) M) by 94 +/- 31%, but had no effect on the contraction to the EDmax of each agonist.

Conclusions: These studies demonstrate: (1) acetylcholine and CCK cause guinea pig gallbladder contraction by both intracellular Ca2+ release and influx of extracellular Ca2+ through voltage-dependent calcium channels; (2) the CCK-induced contraction is more dependent on intracellular Ca2+ than is acetylcholine; and (3) acetylcholine and CCK-induced contractions can by modulated by manipulating influx of extracellular Ca2+ through voltage-dependent calcium channels.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester / pharmacology
  • Acetylcholine / pharmacology*
  • Animals
  • Atropine / pharmacology
  • Calcium / chemistry
  • Calcium / physiology*
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels / drug effects
  • Calcium Channels / physiology*
  • Chelating Agents / chemistry
  • Dose-Response Relationship, Drug
  • Egtazic Acid / chemistry
  • Extracellular Space / chemistry
  • Gallbladder / physiology*
  • Gallbladder / surgery
  • Gastrointestinal Agents / pharmacology*
  • Guinea Pigs
  • Hexamethonium / pharmacology
  • Isometric Contraction / drug effects*
  • Isometric Contraction / physiology
  • Muscarinic Antagonists / pharmacology
  • Muscle, Smooth / drug effects
  • Muscle, Smooth / physiology
  • Nifedipine / pharmacology
  • Potassium / pharmacology
  • Sincalide / pharmacology*
  • Tetrodotoxin / pharmacology

Substances

  • Calcium Channel Blockers
  • Calcium Channels
  • Chelating Agents
  • Gastrointestinal Agents
  • Muscarinic Antagonists
  • Hexamethonium
  • Tetrodotoxin
  • Egtazic Acid
  • 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
  • Atropine
  • Nifedipine
  • Sincalide
  • Acetylcholine
  • Potassium
  • Calcium